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Activation of cell-surface receptors stimulates gener-
ation of intracellular signals that, in turn, direct the
cellular response. However, mechanisms that ensure
combinatorial control of these signaling events are
not well understood. We show here that the Ca2+ and
reactive oxygen intermediates generated upon BCR
activation rapidly engage in a cooperative interaction
that acts in a feedback manner to amplify the early
signal generated. This cooperativity acts by regulat-
ing the concentration of the oxidant produced. The
latter exerts its influence through a pulsed inactiva-
tion of receptor-coupled phosphatases, where the
amplitude of this pulse is determined by oxidant con-
centration. The extent of phosphatase inhibition, in
turn, dictates what proportion of receptor-proximal ki-
nases are activated and, as a result, the net strength
of the initial signal. It is the strength of this initial
signal that finally determines the eventual duration
of BCR signaling and the rate of its transmission
through downstream pathways.
Introduction
Binding of a ligand to a cell-surface receptor often
stimulates an elaborate cascade of signal-transduction
events. Rather than simply represent a linear transmis-
sion of information, proteins involved in signaling build
complex intracellular networks in which signal propa-
gation is controlled in a combinatorial manner (Pawson
and Saxton, 1999; Weng et al., 1999). In addition to
transmission, information processing also represents a
key aspect of intracellular signaling. The functioning of
feedback loops that regulate—either positively or nega-
tively—perpetuation of individual modular constituents
of the signaling pathways largely facilitates such pro-
cessing (Bhalla and Iyengar, 1999; Ferrell, 2002). In
addition, by regulating formation of multimolecular as-
semblies, scaffold (or adaptor) proteins have also been
implicated in the regulation of signal transduction
(Pawson and Scott, 1997; Smith and Scott, 2002). While
the complexity of signaling pathways is being increas-
ingly appreciated, details about how signal output is
modulated are yet to be elucidated. Some of the
parameters that constitute variables in the output are*Correspondence: kanury@icgeb.res.inthe amplitude and duration of signal, in addition to the
rate at which it is transmitted. Little is known, however,
about how context-dependent regulation of these pa-
rameters is achieved (Heinrich et al., 2002).
Lymphocytes provide good model systems for the
study of signal plasticity. Variations in the nature of anti-
gen-receptor-dependent signaling are known to pro-
duce a variety of outcomes ranging from cell prolifera-
tion and differentiation on the one hand to cell death
on the other. The B lymphocyte antigen receptor (BCR)
is a hetero-oligomeric transmembrane protein in which
the surface immunoglobulin (sIg) constitutes the ligand
binding unit, whereas the signaling function is encoded
within the noncovalently associated heterodimer of
CD79a and CD79b (Schamel and Reth, 2000). Three
distinct families of cytoplasmic protein tyrosine kinases
(PTKs)—Src, Syk, and Btk—mediate BCR activation,
with activation of the Src PTKs serving as the critical
first step. The activated BCR then recruits several down-
stream signaling pathways, some of which are those
dependent upon PLCγ, the Rho family of GTPases, and
the Ras/PI-3-K (Kurosaki, 2002).
In this study we examined the dynamics and possible
regulatory mechanisms of signal propagation from the
BCR. We provide evidence to suggest that it is the
strength of the initial signal generated that controls
both the rate and extent of its subsequent progression
through the downstream pathways. The former, in turn,
is shown to depend upon a positive feedback loop that
was rapidly established between two BCR-dependent
second messengers, Cai2+ and reactive oxygen species
(ROS). A rheostat-like function could be assigned to
this loop, in terms of regulating the amplitude and dura-
tion of BCR signaling.
Results
Calcium Dependency of BCR Signaling
We monitored intracellular phosphorylation events in
A20 cells, a murine B cell lymphoma cell line that ex-
presses surface immunoglobulin receptors of the IgG2a
isotype. Cells were pre-equilibrated with [32P]-ortho-
phosphoric acid prior to stimulation with the F(ab)2
fragment of anti-mouse IgG (anti-IgG), and the lysates
were subsequently resolved by two-dimensional gel
electrophoresis (2-DE) for analysis by autoradiography.
Ligation of the BCR also leads to the mobilization of
free calcium ions in the cytoplasm (Cai2+), which consti-
tute important intracellular second messengers for
BCR signaling. Therefore, we also examined for the
consequences of either complete or partial blockage of
the Cai2+ response. BCR-dependent Cai2+ recruitment
occurs in two distinct phases, the first of which in-
volves its release from the intracellular stores in the en-
doplasmic reticulum (ER). Exhaustion of these stores
activates calcium-release-activated channels, which
then promote influx of Ca2+ from the extracellular me-
dium (Winslow et al., 2003). This latter phase is known
as capacitative calcium entry (CCE). The pharmacologi-
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283mission.grams revealed that all of the radiolabeled spots de-
Figure 1. Inhibition of BCR-Dependent Cai2+ Recruitment Inhibits BCR Signaling
(A) shows the autoradiograms obtained upon 2-DE resolution of the proteins from cells stimulated with anti-IgG under the conditions and for
the times indicated. For clarity, only autoradiograms from regions spanning a Mw range of 15 to 75 kDa and a pI range of 5 to 7 are shown.
(Ba) shows the number of new phosphorylation events at various times after stimulation in the absence (B) or presence of either 3 mM EGTA
(C) or 100 mM TMB-8 (;). (Bb) shows the number of new phosphorylation events in anti-IgG-stimulated cells where either EGTA was
supplemented with 1.3 molar equivalent of CaCl2 (B) or TMB-8 addition was combined with 2 mM ionomycin (C). (Bc) shows the profile for
cells either stimulated in Ca2+-free medium (B) or treated with BAPTA-AM (C), or for cells overexpressing EhCaBP (;). The mock-transfected
cells yielded a profile similar to that of uninhibited nontransfected cells. Values given are the mean (±SD) of three separate experiments. (C)
illustrates relative changes in phosphorylation levels of the individual protein spots seen in (A). Data for a randomly selected set of 36 spots
that are commonly present in cells stimulated in the absence (blue line) or presence of either EGTA (green line) or TMB-8 (red line) are shown.
An arbitrary scale is used that reflects the relative levels of phosphorylation (mean values, n = 4) of each spot at the various time points.cal agent TMB-8 inhibits calcium release from the ER,
thereby completely inhibiting the BCR-dependent Cai2+
response (Kubohara and Hosaka, 1999). In contrast,
EGTA can be used to selectively block CCE through
chelation of extracellular Ca2+ (Dolmetsch et al., 1998)
(Figure S1).
The results obtained from such experiments are
shown in Figure 1A. Stimulation of cells with anti-IgG
led to an increase in the number of phosphoproteins
that were detectable. However, inclusion of either EGTA
or TMB-8 proved inhibitory to this response, with TMB-
8 showing the more pronounced effect. Figure 1B pres-
ents an analysis of the number of phosphoproteins de-
tected at each time point after ensuring that these were
not present in the corresponding profile for unstimu-
lated cells. Two “waves” of phosphorylation were evi-
dent in cells stimulated in the absence of a Cai2+ inhibi-
tor (Figure 1Ba). The first, which peaked by 1 min of
stimulation time and declined thereafter up to 5 min of
stimulation, involved rapid phosphorylation of about
100 proteins. A resurgent phase of phosphorylation of
97 newly phosphorylated proteins was then detected
to peak by 10 min of stimulation and was followed by a
gradual decline in the number of phosphoproteins that
persisted over the remainder of the experiment. A care-
ful comparison of the autoradiograms obtained at 1 min
and 10 min of stimulation revealed that only 21 of the
radiolabeled proteins were common to both time points.
Thus, the phosphorylation peak detected at 10 min pre-
dominantly occurs on new substrates that represent
downstream components of BCR signaling. Some of
the phosphoproteins from these two time points could
also be identified by mass spectrometry (Figures S2
and S3).
Stimulation of cells in the presence of EGTA led to a
dampening of BCR signal, where a marked reduction
in intensity of both phosphorylation peaks was clearly
evident (Figure 1Ba). In addition to the quantitative ef-
fect, a delay in the kinetics of phosphorylation was also
discernable. The phosphoproteins observed in both the
1 min and 5 min time points of cells stimulated in the
presence of EGTA were all present in the 1 min peak
from cells stimulated in the absence of an inhibitor. The
peak spread in the presence of EGTA, therefore, de-
scribes delayed phosphorylation of some of the early
BCR-dependent substrates. This kinetic effect was
more pronounced in the second phase of phosphoryla-
tion, normally observed at 10 min in cells stimulated
without any inhibitor. A comparison of the autoradio-tected at 20 min in cells stimulated in the presence of
EGTA were present in the 10 min peak obtained in the
absence of an inhibitor. That is, the inclusion of EGTA
resulted in a delay of 10 min in the phosphorylation of
this subset of proteins. Finally, attenuation of BCR sig-
naling was even more marked when cells were stim-
ulated in the presence of TMB-8. Here the early phase
was severely inhibited, with subsequent events being
virtually undetectable (Figure 1Ba).
That our results describe Cai2+ dependency rather
than nonspecific effects of the inhibitors was verified
by the following additional experiments. The effects of
both EGTA and TMB-8 could be completely reversed
under conditions of calcium supplementation (Figure
1Bb). Furthermore, stimulation of cells in the presence
of Ca2+-deficient medium also yielded results similar to
those obtained with EGTA, whereas substantial signal
dampening was observed in cells stimulated in the
presence of the cell-permeable chelator of intracellular
Ca2+, BAPTA-AM (Figure 1Bc). Finally, we also trans-
fected A20 cells with the gene coding for EhCaBP, a
high-affinity Ca2+ binding protein derived from Enta-
moeba histolytica (Yadava et al., 1997). These cells dis-
played a partial suppression of the BCR-dependent
Cai2+ response (Figure S1). The phosphorylation profile
obtained in anti-IgG-stimulated EhCaBP-expressing cells
is shown in Figure 1Bc. A significant reduction in ampli-
tude of the first phase of signaling is clearly evident,
although it was less pronounced than that obtained
with EGTA. Interestingly, while the intensity of down-
stream signaling was largely unaffected, there was a
substantial delay in its accrual, with the second peak of
phosphorylation appearing only at 20 min of stimulation
(Figure 1Bc).
Thus, the data in Figure 1Ba identify a graded effect
in which selective blockage of CCE produces a less
severe inhibition than that obtained upon complete
suppression of BCR-dependent Cai2+ mobilization. It is
presumably due to the profound inhibition of the early
phase of signaling in the presence of TMB-8 that down-
stream signals also do not accumulate. In comparison,
the relatively less pronounced effect of EGTA led to a
situation where, in addition to attenuation, there was a
“slowing down” of the partial signaling capability that
was retained. This was especially evident for the sec-
ond phase of phosphorylation, normally seen at 10 min
in the absence of an inhibitor. In other words, the inten-
sity of the first phase of signaling appears to have a
significant impact on that of the downstream events, in
addition to the kinetics of subsequent signal trans-
Cell
284Figure 1C presents the kinetic profiles for individual t
trandomly selected phosphoprotein spots. A significant
effect of EGTA addition is clearly evident in virtually all C
aof the cases examined and involved a reduction in
either magnitude (e.g., spots 1, 2, 5, and 6), kinetics of (
2phosphorylation (e.g., spots 3, 8, 16, 29, and 30), or
both (e.g., spots 10, 12, and 25). As expected, TMB-8 a
caddition produced a more complete inhibition relative
to EGTA. The few exceptions nonetheless had to ex- r
cperience a significant time lag before undergoing phos-
phorylation. Thus, while the data in Figure 1B detail the p
Ptime-dependent flux in phosphorylation events as a
consequence of Cai2+ inhibition, the results in Figure (
l1C highlight that this flux was not restricted to a spe-
cific subset of target proteins. Rather, the latter de- i
bscribe it as a “global” phenomenon in which at least a
significant proportion of intermediates in the BCR sig- s
dnaling pathway are affected.
tThe Regulatory Effect of Cai2+ Is Enforced
through a Feedback Pathway C
sNext, we again performed the anti-IgG stimulation ex-
periments, but in cells that were not labeled with radio- o
tactive phosphate. Lysates were immunoprecipitated
with antibodies against known intermediates in BCR b
asignaling, and the phosphorylation status of these
targets was determined by Western blots. Regardless s
Cof the target probed, conditions of Cai2+ suppression
consistently led to a decrease in the magnitude of phos- i
nphorylation, with TMB-8 showing the more pronounced
effect relative to EGTA (Figure 2). A lag in maximal p
rphosphorylation of Syk was also noted in the presence
of EGTA. With the exception of ERK1/2, phosphoryla- aFigure 2. Cai2+ Dependency of BCR Sub-
strate Phosphorylation
Cells were stimulated with anti-IgG for the
indicated times in the absence (None) or
presence of either EGTA or TMB-8. The
phosphorylation status of the indicated pro-
teins was then examined through immuno-
precipitation with specific antibodies fol-
lowed by Western blot for either the amount
of target protein present (P) or the extent of
its phosphorylation (pP). For the latter, anti-
phosphotyrosine antibodies were used in all
cases, except for ERK1/2, where anti-phos-
pho-ERK antibodies were employed.ion of all the remaining proteins studied in fact consti-
utes events that are upstream of the step involving
ai2+ recruitment. BCR engagement leads first to the
ctivation of Src PTKs, which include Lyn and Lck
Campbell and Sefton, 1992; Fuentes-Panana et al.,
004). Activated Lyn then phosphorylates BCR-associ-
ted CD79a and CD79b, following which Syk is re-
ruited at these sites. This process constitutes a pre-
equisite for activation of the downstream signaling
omponents, one of which includes the Syk-dependent
hosphorylation and activation of PLCγ. Activated
LCγ cleaves phosphatidylinositol 4,5-bisphosphate
PIP2) to generate IP3 as one of the secondary metabo-
ites. Here the adaptor protein BLNK plays a critical role
n both the recruitment of PLCγ2 to the plasma mem-
rane and positioning it in proximity with PIP2 (Kuro-
aki and Tsukada, 2000). The IP3 thus generated in-
uces Cai2+ release from the ER.
Our finding that Lyn phosphorylation was Ca2+ sensi-
ive (Figure 2) therefore suggested that the effect of
ai2+ deprivation was likely exercised at a very early
tep in the BCR signaling pathway. As phosphorylation
f Src PTKs, and Lyn in particular, is thought to consti-
ute the initiating event in BCR signaling, it was plausi-
le that this perturbation in Lyn phosphorylation could
ccount for the global effect of Cai2+ blockage on BCR
ignaling. Consequently, we next studied the effects of
ai2+ depletion on activation of the Lyn kinase. Lyn was
mmunoprecipitated from stimulated cells and its ki-
ase activity measured using an exogenous synthetic-
eptide substrate. Stimulation with anti-IgG led to a
apid activation of Lyn kinase that peaked between 1
nd 5 min of stimulation time (Figure 3A). Importantly,
Control of Receptor Signaling
285Figure 3. Cai2+ Deprivation Results in Dimin-
ished Activation of Lyn
In (A), Lyn was immunoprecipitated from
cells (2 × 107/group) stimulated for the indi-
cated times in the absence (B) or presence
of either EGTA (C) or TMB-8 (;). These im-
munoprecipitates were then employed in a
phosphorylation assay using a synthetic
peptide as substrate. Results give the net in-
corporation of radioactive phosphate in the
substrate after background subtraction. In
(B), untreated cells (B) or cells treated with
either EGTA (C) or TMB-8 (;) were stim-
ulated for 1 min with anti-IgG. The Lyn immu-
noprecipitates thus obtained were used in a substrate phosphorylation assay where substrate phosphorylation was monitored as a function
of time. Values shown represent the time-dependent increase in peptide phosphorylation. In both (A) and (B), values are the mean (±SD) of
four experiments where each experiment was performed in triplicate sets.Lyn activation was severely compromised in samples
obtained from cells stimulated in the presence of either
EGTA or TMB-8. This was especially evident at the early
time points, where the inhibition was again greater with
TMB-8 relative to that with EGTA. In addition to the
magnitude, Lyn obtained from Cai2+-deprived cells also
displayed a reduction in the kinetics of substrate phos-
phorylation (Figure 3B). EGTA treatment resulted in a
5- to 6-fold reduction in the rate of substrate phosphor-
ylation, whereas the difference in the corresponding
rates between samples from EGTA- versus TMB-8-
treated cells was about 1.4-fold. Thus, the BCR-depen-
dent Cai2+ response directly regulates the proportion of
available Lyn molecules that are activated. This, in turn,
regulates both the extent and rate of substrate phos-
phorylation that is achieved by this kinase.
BCR Engagement Leads to a Cai2+-Dependent
Generation of ROS
A second messenger function for ROS has been impli-
cated in diverse receptor systems, including those for
EGF, PDGF, insulin, and the TCR, among others (Finkel,
2003; Nathan, 2003; Devadas et al., 2002). Signal acti-
vation of lymphocyte receptors has been proposed to
occur through H2O2-mediated inhibition of protein tyro-
sine phosphatase (PTP) activity, thereby shifting the
equilibrium in favor of kinase activation (Reth, 2002;
Reth and Brummer, 2004). Therefore, we next probed
whether stimulation of A20 cells with anti-IgG results in
the production of ROS using cells that were labeled
with a ROS-sensitive dye, DCFDA. A rapid induction of
ROS was observedthat was evident within seconds of
addition of anti-IgG (Figure 4A). This anti-IgG-depen-
dent ROS induction could be inhibited by the addition
of either the glutathione peroxidase mimetic ebselen or
the antioxidant N-acetylcysteine (NAC) (Figure 4A) but
not by the NO scavenger L-N-monomethyl arginine (not
shown). Furthermore, overexpression of either catalase
or peroxiredoxin 1 (Prdx1)—both of which are known
H2O2 scavengers—also led to inhibition of the anti-IgG-
induced ROS response (Figure 4A). These results cu-
mulatively demonstrate that stimulation of BCR leads
to the rapid generation of ROS, which is at least largely
comprised of H2O2.
Optimal BCR-dependent ROS induction required the
prior activation of PTK and PI3K. Inhibition of either thePTK activity with genistein or the PI3K activity with
wortmannin led to a significant reduction in anti-IgG-
dependent ROS production (Figure 4B). Thus, activa-
tion of BCR signaling is required for generation of at
least a significant proportion of the ROS detected.
BCR-dependent ROS production was also significantly
inhibited in the presence of either EGTA (w60%) or
TMB-8 (w75%) (Figure 4C). Significantly, this inhibitory
effect was exercised at the earliest time points of ROS
detection (Figure 4C, inset) and could be reversed un-
der conditions of Ca2+ supplementation (Figure S4).
Suppressed anti-IgG-dependent ROS responses could
also be demonstrated in cells treated with BAPTA-AM
and in cells suspended in Ca2+-deficient medium (Fig-
ure 4C). These results reveal that the inhibition of BCR-
dependent Cai2+ recruitment results in a concomitant
inhibition of the BCR-dependent ROS response.
Consistent with earlier suggestions (Qin et al., 2000;
Reth, 2002), we found that suppression of BCR-initi-
ated ROS generation also resulted in an attenuated
Cai2+ response. This could be demonstrated in cells
stimulated in the presence of antioxidants such as eb-
selen or NAC as well as in cells overexpressing either
catalase or Prdx1 (Figure 4D). Thus, these cumulative
findings identify the existence of a positive feedback
loop between the BCR-dependent Cai2+ and the BCR-
dependent ROS responses. Furthermore, the inhibitory
effect of EGTA and TMB-8 on the BCR-dependent ROS
levels was dose dependent (Figure 4E), as was the ef-
fect of ROS scavengers on the BCR-activated Cai2+ re-
sponse (Figure 4F). These latter results thus describe
the Cai2+-ROS loop as a monostable system that can
display graded shifts in its steady-state equilibrium. A
sigmoidal dose-response curve is expected for bistable
systems, whereas incremental effects are characteristic
of monostable systems (Ferrell, 2002).
To probe for a regulatory effect of the Cai2+-ROS
loop, we next examined Lyn phosphorylation after se-
lectively depleting either of these two species. Our in-
terest being in the early signaling events, we focused
on the 30 s time point of stimulation with anti-IgG. Both
EGTA and TMB-8 led to a marked reduction in inducible
Lyn phosphorylation, which could be reversed by Ca2+
supplementation (Figure 5A). A similar effect was noted
in cells that were either treated with BAPTA-AM or sus-
pended in medium that was deficient for Ca2+ prior to
stimulation (Figure 5A), further confirming a role for
Cell
286Figure 4. Cooperativity between Cai2+ and ROS Pathways
(A)–(C) profile the generation of ROS as measured by DCFDA oxidation. Briefly, DCFDA-labeled A20 cells were plated at 1 × 106/100 l in
wells of a 96-well plate, and the fluorescence signal obtained after stimulation with anti-IgG under the various conditions employed was
recorded for the periods shown. Results for cells stimulated with anti-IgG in the absence of any inhibitor (B) are shown in all panels. In (B)
and (C), the profile for mock-stimulated (i.e., medium-only) cells is also included (,). The arrow indicates the time of addition of anti-IgG. (A)
gives the results for cells stimulated with anti-IgG in the presence of either 15 mM ebselen (■) or 25 mM NAC (C) or in cells transfected with
either catalase (7) or Prdx1 (;). The profile obtained upon stimulation of mock-transfected (i.e., vector-only) cells did not differ significantly
from that in untransfected cells. Values shown are after subtracting the corresponding values for mock-stimulated cells at each of these time
points. (B) depicts ROS in cells stimulated with anti-IgG in presence of either 100 nM wortmannin (C) or 50 g/ml of genistein (;). (C) shows
ROS production in cells stimulated in the presence of either 3 mM EGTA (C), 5 mM BAPTA-AM (■), or 100 mM TMB-8 (;) or suspended in
Ca2+-free medium prior to stimulation (7). The inset compares profiles obtained with EGTA, TMB-8, or BAPTA-AM and cells stimulated
without inhibitor within the first 36 s after anti-IgG addition. (D) depicts the Cai2+ responses in Fluo-3-AM-loaded A20 cells stimulated either
alone (line 1) or in the presence of 10 mM NAC (line 2) or in cells overexpressing either Prdx1 (line 3) or catalase (line 4). (E) shows the dose-
dependent inhibition of anti-IgG-stimulated ROS generation in response to increasing doses of either TMB-8 (:) or EGTA (C); data given are
the mean (±SD) of four separate experiments. (F) shows the dose-dependent inhibition of the Cai2+ response by ebselen as monitored by
FACS. Fluo-3-AM-loaded cells were stimulated with anti-IgG in the absence (line 1) or presence of 2 mM (line 2), 5 mM (line 3), or 15 mM (line
4) ebselen.
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Lyn immunoprecipitation was done from cells stimulated for 30 s under different conditions and probed for phosphotyrosine. Lyn phosphoryla-
tion was quantified by densitometry; values are presented as fold increase over that obtained for Lyn in mock-stimulated cells. In (A), group
1 represents cells stimulated with anti-IgG. Groups 3–7 represent cells stimulated with anti-IgG in the presence of EGTA, TMB-8, BAPTA-AM,
EGTA plus CaCl2, and TMB-8 plus ionomycin, respectively. Group 2 shows the results obtained in cells suspended in Ca2+-free medium. (B)
gives the corresponding results obtained in cells treated with either ebselen (group 2), ebselen plus ionomycin (group 3), NAC (group 4), or
NAC plus ionomycin (group 5). Data for cells overexpressing either catalase (group 6) or Prdx1 (group 7) are also shown, along with the
corresponding values obtained in mock-transfected cells (group 1). (C) shows the effect of stimulation of cells with either anti-IgG (group 1),
H2O2 (group 2), or sodium pervanadate (group 3). The consequences of stimulation with sodium pervanadate in the presence of either EGTA
(group 4) or TMB-8 (group 5) are also depicted. Values shown in (A)–(C) are the mean (±SD) of three independent experiments.Cai2+ in regulating BCR-dependent Lyn phosphory-
lation.
The H2O2 scavengers ebselen and NAC were equally
capable of inhibiting BCR-dependent Lyn phosphoryla-
tion, as was the overexpression of either catalase or
Prdx1 (Figure 5B). The addition of ionomycin, however,
had no effect on this inhibition, suggesting a redun-
dancy of Cai2+ in this process. Consistent with a role
for ROS in Lyn phosphorylation, addition of either H2O2
or pervanadate to A20 cells also led to enhanced phos-
phorylation of Lyn (Figure 5C). While exogenous ROS is
known to induce Cai2+ recruitment in B cells (Reth,
2002), this effect was not inhibited by the addition of
either EGTA or TMB-8 (Figure 5C). These results, there-
fore, highlight a regulatory role for the Cai2+-ROS loop
during BCR-dependent phosphorylation of Lyn. Fur-
thermore, our demonstration that Lyn phosphorylation
was insensitive to the effects of Cai2+ depletion in the
presence of exogenous ROS, combined with the fact
that Ca2+ supplementation was unable to alleviate the
inhibitory effects of ROS scavengers, reveals that it is
the ROS that directly mediates this effect. The Cai2+
then likely influences the levels of ROS available. This
interpretation is consistent with our findings that inclu-
sion of ebselen during stimulation of cells with anti-IgG
also leads to a global dampening of BCR signals (Fig-
ure S5).
The Cai2+-ROS Loop Regulates Phosphatase
Activities Associated with the BCR
A likely target candidate for the action of ROS are the
PTPs, which have a redox-regulated cysteine in their
catalytic site (Zhang, 1998; Reth, 2002). As the effect
of ROS suppression was evidenced at the level of Lyn
phosphorylation, we anticipated that the putative target
PTP would be one that is either in close proximity to or
associated with the BCR. The association of the PTPSHP-1 with the BCR has previously been demonstrated
in murine B cells, and a deficiency in SHP-1 activity
was correlated with hyperresponsiveness to BCR stim-
ulation in terms of both proliferation and intracellular
signaling (Pani et al., 1995). Experiments involving sIgG
immunoprecipitations followed by aWestern blot analysis
also confirmed the association of SHP-1 with the BCR
in A20 cells. This association was stable to the effects
of BCR stimulation and was resistant to the effects of
either EGTA or TMB-8 addition (Figure 6A). The associ-
ation of SHP-1 with the BCR was further confirmed
through mass spectrometric analysis of tryptic digests
generated from the immunoprecipitates obtained from
unstimulated cells (data not shown). The latter experi-
ments failed to reveal the presence of any additional
PTP, suggesting that SHP-1 constitutes at least the pre-
dominant PTP associated with the BCR.
We next monitored BCR-associated PTP activity as
a function of stimulation time. A rapid but transient in-
activation was observed in samples from cells stim-
ulated in the absence of any added inhibitor (Figure
6B). Inhibition was detected by 15 s after stimulation,
with maximal levels (w60% inhibition) being achieved
at 30 s. Surprisingly, the PTP activity was then rapidly
restored to slightly above basal levels by 1 min and
remained relatively invariant thereafter (Figure 6B). Ad-
dition of either EGTA or TMB-8 prevented this inhibi-
tion, with TMB-8 in fact yielding an enhancement in
PTP activity at the early time points (Figure 6B).
Addition of the ROS scavengers ebselen or NAC also
led to a complete suppression of BCR-associated PTP
inactivation induced by anti-IgG (Figure 6C), which was
similar to the effects of overexpression of either cata-
lase or Prdx1 (Figure 6C). That the observed PTP inacti-
vation was mediated by ROS could be confirmed in ad-
ditional experiments employing pervanadate as the
stimulant instead of anti-IgG. An inhibition profile sim-
Cell
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Cells (5 × 107/aliquot) were stimulated with anti-IgG in the presence or absence of various inhibitors for the times indicated. Cell lysates were
then subjected to immunoprecipitation with either anti-mouse IgG (A–C) or anti-B220 (B cell-specific isoform of CD45) antibodies (F). (A)
shows the Western blot results when immunoprecipitates from the various groups were probed for either the Ig heavy chain (IgH, as loading
control) or the presence of SHP-1. The SHP-1 blots were then stripped free of bound antibody and reprobed with anti-phosphotyrosine
antibodies (pSHP-1). In (B) and (C) an identical protocol was employed, except that the immunoprecipitates were employed in an assay for
detecting phosphatase activity. Profiles shown in (B) are for cells stimulated in the absence (B) or presence of either EGTA (C) or TMB-8
(;). (C) gives the corresponding results obtained in either mock-transfected cells (B), cells transfected with a vector coding for Prdx1 (C)
or catalase (;), or the presence of ebselen (7). Inset shows the results obtained upon stimulation of cells with pervanadate instead of anti-
IgG. The supernatants remaining after sIgG-immunoprecipitation were subjected to a second round of immunoprecipitation with anti-SHP-1
antibodies. Results of a phosphatase-activity assay on this precipitate are shown in (D). The groups are cells stimulated in the absence (B)
or presence of either ebselen (C) or TMB-8 (;). (E) depicts the effects of increasing ebselen concentrations at 30 s of anti-IgG stimulation
on BCR-associated PTP activity (B), BCR-dependent ROS production (C), and BCR-dependent Lyn phosphorylation (;) in A20 cells. For
comparison, values are normalized in terms of percent of the maximal inhibition obtained (i.e., anti-IgG alone for PTP activity and 20 mM
ebselen for ROS and Lyn phosphorylation). (F) depicts the phosphatase activity obtained from CD45 (or B220) immunoprecipitates. The
various groups are cells stimulated without an inhibitor (B) or with either EGTA (C), TMB-8 (;), or ebselen (7). Inset shows the effect on
the activity of CD45 of stimulating cells with pervanadate. No additional effect was detected here upon addition of either EGTA or TMB-8.
Data presented in (B)–(F) are the mean (±SD for [B]–[D]) of between three and five experiments.ilar to that of anti-IgG was obtained (Figure 6C, inset), c
valthough neither EGTA nor TMB-8 addition was able to
overcome the inhibition in this case. These results indi- Pate that it is the BCR-initiated ROS that is directly in-
olved in the transient inhibition of BCR-associated
TP activity, the latter probably deriving from SHP-1.
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activity was reversed simply by incubation of the immu-
noprecipitates for a brief period with DTT (data not
shown), supporting that inactivation involved reversible
oxidation of a cysteine residue in the PTP. Importantly,
anti-IgG-mediated inhibition of PTP activity was found
to be restricted to the BCR-associated pool of SHP-1.
No inhibitory effect could be detected on SHP-1 that
was directly immunoprecipitated from cell lysates that
had been first depleted of the BCR (Figure 6D). Rather,
an increase in activity was observed that was not fur-
ther affected upon addition of either Cai2+ or ROS inhib-
itors (Figure 6D). Thus, it appears that the action of ROS
is specific to the BCR-associated SHP-1.
A direct correlation between available ROS concen-
trations, the consequent inactivation of BCR-associ-
ated PTP, and BCR-dependent Lyn phosphorylation
could be verified in experiments using ebselen as an
exogenous ROS inhibitor. Stimulation of cells with anti-
IgG in the presence of increasing ebselen concentra-
tions led to a dose-dependent inhibition in ROS pro-
duction (Figure 6E). Importantly, this also resulted in a
corresponding dose-dependent reduction in the extent
of PTP inactivation along with a progressive decrease
in BCR-dependent Lyn phosphorylation (Figure 6E).
These findings provide experimental support for our
proposal that the Cai2+-ROS loop represents a mono-
stable system that is capable of calibrating signal out-
put from the BCR.
In addition to the effect on BCR-associated PTP ac-
tivity, stimulation of A20 cells with anti-IgG also resulted
in a rapid but transient inactivation of CD45 (B220), a
transmembrane PTP that plays a critical role in con-
trolling BCR signal transduction (Alexander, 2000) (Fig-
ure 6F). Stimulation of cells in the presence of inhibitors
of either Cai2+ or ROS led to a reversal of this inhibition
(Figure 6F). Furthermore, a similar inhibition in CD45 ac-
tivity was also obtained upon stimulation with sodium
pervanadate instead of anti-IgG, and this inhibitory ef-
fect was now insensitive to both EGTA and TMB-8 (Fig-
ure 6F, inset). Thus, in addition to the BCR-associated
PTP, the Cai2+-ROS feedback loop also appears to reg-
ulate enzymatic activity of CD45 in a ROS-dependent
manner.
BCR-Dependent ROS Production Is Mediated
through DUOX1
While the enzymatic component responsible for BCR-
dependent ROS generation remained unknown, NADPH
oxidases (NOX) have been implicated for a variety of
receptors, including the TCR (Jackson et al., 2004). To
test for such a possibility, we next stimulated cells in
the presence of a flavin-dependent oxygenase inhibitor,
diphenylene iodonium (DPI). This treatment resulted in
a significant inhibition of the early BCR-dependent ROS
response (Figure 7A). Importantly, the inclusion of DPI
during stimulation significantly inhibited the BCR- but
not the H2O2-dependent phosphorylation of Lyn (Figure
7B), implicating the involvement of an NADPH oxidase
in at least some of the early BCR-dependent H2O2 pro-
duction.
Of the NOX family members, it is the human NOX5
that is regulated by cytosolic Ca2+ concentrations(Banfi et al., 2004). However, such Cai2+-regulated NOX
members have not yet been described in mice. Further-
more, a comparison of the sequence of the human
NOX5 (hNOX5) gene against the mouse genome data-
base also did not identify any closely related homologs.
However, an annotated murine cDNA sequence iden-
tified as DUOX1 (accession number XM_130483.4) was
discovered that displayed 87% sequence identity with
that of its human DUOX (dual oxidases) counterpart.
DUOX represents the second family of nonphagocytic
NADPH oxidases that depend upon either gp91phox or
its related proteins (Lambeth et al., 2000). This class
of enzymes possesses two EF hand motifs, and Cai2+-
activated superoxide production has previously been
suggested for the human homologs (Nakamura et al.,
1991; Banfi et al., 2001).
Thus, in the absence of a murine NOX5 homolog,
DUOX1 seemed a likely candidate to be involved in
BCR-dependent ROS production. Our subsequent ex-
periments revealed that DUOX1 was indeed expressed
in A20 cells, in addition to a few other B cell lines and
normal mouse splenic B cells. This was confirmed both
by Northern blot hybridization and reverse transcriptase-
PCR experiments with isolated mRNA (Figure S6).
To examine the role of DUOX1, we next performed
gene-silencing experiments using a combination of
double-stranded siRNAs targeting two nonoverlapping
regions from the annotated cDNA sequence of the
DUOX1 gene. This approach led to a substantial reduc-
tion in the specific mRNA levels by 48 hr posttransfec-
tion (Figure 7C). Significantly, suppression of DUOX1
expression led to a concomitant inhibition of the early
ROS response that is obtained upon BCR triggering
(Figure 7D). No such inhibition could be observed in
the negative control where cells were transfected with
nonsilencing oligonucleotide sequences (Figure 7D). In
addition to ROS, the BCR-dependent Cai2+ response
was also markedly attenuated in cells transfected with
the silencing, but not the control, siRNA (Figure 7E).
Finally, BCR-dependent phosphorylation of Lyn was
also negatively affected in cells displaying reduced
DUOX1 expression (Figure 7F). These results, therefore,
strongly implicate DUOX1 as constituting at least one
of the components responsible for the early phase of
the BCR-dependent ROS response. Thus, it is the
DUOX1-mediated ROS that appears to be involved in
establishing the Cai2+-ROS feedback loop and, thereby,
influencing BCR-dependent Lyn phosphorylation.
Discussion
While Cai2+ is known to drive several downstream path-
ways (Winslow et al., 2003), the global dampening of
BCR signaling seen upon inhibition of Cai2+ was unex-
pected. At least within the time frame of our experi-
ment, the signals emanating upon BCR activation could
be differentiated into two sequential peaks of phos-
phorylation that occurred at 1 min and 10 min of stimu-
lation, respectively. Interestingly, both of these phases
were significantly attenuated when BCR-dependent
Cai2+ mobilization was inhibited with either EGTA or
TMB-8. However, the graded inhibitory effect, depend-
ing on whether Ca 2+ blockage was complete or merelyi
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DCFDA-labeled A20 cells were stimulated with anti-IgG in the absence (B) or presence of DPI (15 M, 7); the resulting increase in the
fluorescence signal obtained over a subsequent 60 s period is shown in (A). Also included here is the profile obtained in unstimulated cells
(C). (B) depicts the fold increase in Lyn phosphorylation in cells stimulated with either anti-IgG (groups 1 and 2) or H2O2 (groups 3 and 4) in
the absence (groups 1 and 3) or presence (groups 2 and 4) of DPI. Values are the mean (± SD) of three independent experiments. (C) shows
the results of a semiquantitative RT-PCR analysis of total RNA obtained, 48 hr later, from cells transfected with either silencing (lane 2) or
nonsilencing (lanes 4 to 6) siRNA. Nonsilencing siRNA was targeted against either aminopeptidase-N from Spodoptera litura (lane 4), lucifer-
ase (lane 5), or murine SMAR-1 (lane 6). DUOX1 expression in cells prior to siRNA treatment is shown in lane 1. Parallel PCR was also done
on the mRNA preparation from A20 cells after omitting the reverse transcriptase reaction to verify that contaminating genomic DNA was not
being amplified (lane 3). (D) shows the early anti-IgG-induced ROS responses obtained in cells that were transfected with either DUOX1-
silencing (C) or nonsilencing (B) siRNA. Also included is the corresponding profile obtained in unstimulated cells (;). (E) profiles the
corresponding BCR-dependent Cai2+ response (line 1, negative control; line 2, DUOX1-silenced cells). Lyn phosphorylation (P-Lyn) obtained
is shown in (F) in cells that were transfected with either irrelevant (lanes 1 and 2) or silencing (lanes 3 and 4) siRNA in either the presence (S)
or absence (U) of 1 min stimulation with anti-IgG. These blots were subsequently stripped and reprobed with antibodies specific for the Lyn
protein (Lyn) to verify comparable protein load in the lanes.restricted to the CCE phase, proved to be particularly C
pinformative. Addition of TMB-8 during stimulation caused
a severe attenuation in the primary phase of signaling, i
eas a result of which the second phase was virtually un-
detectable. As opposed to this, selective inhibition of pCE with EGTA led to a less severe inhibition in the first
eak of signaling but was accompanied by a time lag
n the generation of the second peak. At least on an
mpirical level, these collective findings permit two im-
ortant inferences to be drawn. First, the strength of
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which it eventually progresses. This interpretation is
supported by our observations that the extent of inhibi-
tion of the primary phosphorylation events determined
the intensity of the latter phase. Second, the strength
of the initial signal generated also likely determines the
subsequent rate of signal progression. This was evident
in the intermediate situation of CCE blockage, where
time lags in signal accumulation were noted. Our pro-
posal that both the extent and rate of signal pro-
gression depend upon the amplitude of the initial signal
is easily rationalized simply by considering the law of
mass action. Thus, in any sequential process the con-
centration of the active intermediate generated at any
given step may be expected to determine the facility,
in terms of both magnitude and rate, with which the
subsequent step will occur.
From a mechanistic point of view, it was intriguing
that the effect of Cai2+ was enforced at a point in the
pathway that preceded the initiation of BCR signaling
(Lyn phosphorylation). Experimental support for this
feedback interaction revealed to us the framework
within which BCR signal amplification could be achieved.
This was visualized as follows: ligation of the BCR first
leads to a relatively low-intensity activation of BCR sig-
naling; the Cai2+ thus recruited rapidly establishes a
self-sustaining feedback loop that leads to signal am-
plification from its point of origin. Our results indicate
that this feedback cooperativity is instituted at least
within seconds of BCR activation. Subsequent resolu-
tion revealed that Cai2+ acted by potentiating BCR-
dependent production of ROS. A positive cooperativity
between the BCR-dependent Cai2+ and the BCR-depen-
dent ROS pathways was indeed identified in which inhi-
bition of one led to a concomitant inhibition of the
other.
The predominant oxidant species produced in re-
sponse to stimulation of A20 cells with anti-IgG ap-
pears to be H2O2, at least as deduced from the experi-
ments described here. Importantly, ROS was rapidly
induced, being detectable within seconds of addition
of anti-IgG. Furthermore, the effect of Cai2+ on ROS
levels was also evident from the earliest time point of
detection of ROS. In this context our present results
identify DUOX1 as at least one of the enzymatic com-
ponents responsible for the early BCR-dependent ROS
production. Our experiments employing siRNA re-
vealed that DUOX1 is critical for establishing the BCR-
dependent Cai2+-ROS feedback loop and, thereby, en-
suring optimal phosphorylation of Lyn following BCR
activation.
While both the BCR-dependent Cai2+ and ROS path-
ways influenced each other, it was the ROS that ulti-
mately affected BCR signaling. This was determined
from experiments indicating that, whereas the inhibi-
tory effect of Cai2+ could be overcome by independent
elevation in ROS levels, the converse was not true. Fur-
thermore, the effect of ROS suppression was evident at
the level of Lyn phosphorylation, as a result of which
both the magnitude and kinetics of substrate phos-
phorylation by Lyn were attenuated. Since Lyn—along
with the other Src kinases—constitutes the initiating
event in BCR signaling, we speculate that it is the effectof ROS on Lyn activation that then impacts the subse-
quent signaling events.
The ROS produced upon BCR activation was found
to act through inhibition of PTPs. Notable here was the
effect on BCR-associated SHP-1, where the inhibition
was spatially localized with no effect on the cytoplas-
mic pool of SHP-1. A similar inhibition was also ob-
tained for CD45, a transmembrane PTP involved in the
regulation of BCR signaling. Importantly, ROS-medi-
ated inactivation of PTP was in turn regulated through
the receptor-initiated recruitment of Cai2+. In view of the
fact that the ROS production upon BCR activation was
relatively stable, the transient inhibition of PTP activity
obtained was, however, somewhat surprising. While the
reason for this is not presently clear, more recent exper-
iments have determined the antioxidant protein perox-
iredoxin 4 (Prdx4) to be associated with the BCR (Figure
S7). Whether such BCR-associated antioxidant pro-
teins in fact regulate ROS-mediated PTP inhibition,
however, remains to be established. In any event, a
similar transient PTP inactivation was obtained when
cells were stimulated with pervanadate instead of anti-
IgG. More importantly, short-lived ROS-mediated PTP
inhibition has also been noted during activation of other
receptor systems (Lee et al., 1998; Mahadev et al.,
2001; Meng et al., 2002). Collectively, then, our present
results, along with these earlier findings, strongly sug-
gest that a pulsed inactivation of the receptor-coupled
PTP is sufficient to shift the balance in favor of signal
activation. In this context we consider it likely that, by
varying the extent of PTP inactivation, the Cai2+-ROS
loop acquires a rheostat-like function in terms of modu-
lating the strength of BCR signaling. This is based on
our description of this loop as a monostable system,
along with the fact that additional pathways that control
the concentrations of Cai2+ and ROS produced in re-
sponse to BCR triggering have recently been charac-
terized (Nishida et al., 2003; Saito et al., 2003). That
calibrated shifts in the Cai2+-ROS equilibrium can lead
to a graded output is experimentally supported by our
demonstration of the dose-dependent correlation be-
tween ROS concentrations available, the extent of inac-
tivation of the BCR-associated PTP, and the magnitude
of BCR-dependent Lyn phosphorylation. In other words,
it is the Cai2+-ROS feedback loop that likely determines
the dimensions of time and space in terms of propaga-
tion of the BCR-generated signals.
In summary, we identify here the existence of a posi-
tive feedback loop between receptor activation-depen-
dent Cai2+ and ROS that regulates BCR signal strength
right at its point of origin. The central nature of this loop
was revealed from the fact that its perturbation led to
a global dampening of signals. Our results further sug-
gest that it is the strength of the initial signal that deter-
mines the extent to which it progresses, in addition to
the speed with which the endpoint is reached. Finally,
we also characterize the Cai2+-ROS loop as a mono-
stable system. This property would enable a rheostat-
like function for this loop, with feeder pathways likely
to confer on it a “tuning” capability with respect to BCR
signal amplification. Finally, given the common usage
of both Cai2+ and ROS as second messengers, it would
be of interest to determine whether such a Ca 2+-ROSi
Cell




PStimulation of Cells and the Resolution of Phosphorylated
TProteins by 2-DE
nA20 cells (2 × 107) were placed in phosphate-free DMEM supple-
2mented with 1% FCS for 2 hr, following which [32P]-orthophos-
sphoric acid (0.5 mCi/ml) was added and the culture continued for
oan additional 4–5 hr. They were then stimulated with the F(ab)2 frag-
ment of goat anti-mouse IgG at a final concentration of 25 g/ml
for the indicated times. Where necessary, the appropriate inhibitor
Swas added at 10 min prior to stimulation (EGTA and TMB-8 at final
Sconcentrations of 3 mM and 100 M, respectively). The cytoplas-
amic fractions of cell lysates were then resolved by 2-DE as pre-
viously described (Gorg et al., 2000). Resolution in the first dimen-
sion was achieved using 13 cm IPG dry strips (pH 4–7), and a 12%
ASDS polyacrylamide gel was used to resolve in the second dimen-
sion. Comparable loading in all the groups was ensured through
Tsilver staining of the resultant gels. Dried gels were then exposed
Rto X-ray films.
MPhosphoproteins were visualized by autoradiography and digi-
btized on a Molecular Dynamics computing densitometer using Im-
tageQuant software (Amersham Biosciences). Only those spots with
man area greater than 75 pixels were considered, and the minimum
tintensity surrounding the spot on the film was taken as its back-
Dground and subtracted to give the true intensity. Relative quantifi-
Mcation was achieved by normalizing against three distinct spots
that were unaffected upon anti-IgG stimulation of cells. Calibration
Rfor the Mw and pI was done on the basis of standard markers that
Rwere run on parallel gels.
A
PTransfection of Cells
The gene for human Cu/Zn superoxide dismutase was a generous
Rgift from J. Subramanium (IIT Kanpur, India), that for mouse Prdx1
from S. Watabe (Yamaguchi University, Japan), and that for EhCaBP
Afrom S. Sopory (ICGEB, India). The human catalase gene was ob-
atained by RT-PCR. Each of these genes was cloned into an appro-
1priate series of the mammalian expression vector pcDNA3.1-Myc/
His (Invitrogen). Linearized plasmid DNA (20 µg) was transfected B
by electroporation (260 V, 950 F) of A20 cells (2 × 107) followed by m
selection in a medium containing G418 (1.2 mg/ml). Experiments d
were done at 3 days posttransfection, and parallel transfections 3
were performed with the lacZ gene as a positive control. High ex- B
pression of the Myc/His-tagged proteins was confirmed through K




A combination of two 21-mer siRNA duplexes specific to the anno-
Ctated cDNA sequence of DUOX1 with two-nucleotide (dT) 3# over-
Bhangs was used to downregulate DUOX1 expression (target se-
oquences: TTGAGACAAAGTGAGAATTAA and GAGCACTGTTTAAGA
2ACTATA). Each siRNA duplex was used at 10 g/5 × 106 cells, and
Dtransfection was achieved using the RNAiFect kit (Qiagen) and
Mstrictly following the protocol recommended by the manufacturer.
oThe negative-control siRNAs used are described in the legend to
gFigure 7. After 2 days in culture, cells were harvested and then
Janalyzed for the various parameters described in the text.
D
Lyn Kinase Assay i
Lyn was first immunoprecipitated from the various groups (5 × 107 3
cells/group/time point) described in the text. The immunoprecipi- F
tates were washed and then incubated in the kinase reaction buffer t
(25 mM Tris [pH 7.5] containing 0.5 mM DTT, 0.1 mM orthovana- C
date, 50 M unlabeled ATP, 10 mM MgCl2, and 10 Ci/tube of [32P]- F
ATP). The reaction was initiated through the addition of a 5 M
C
final concentration of the synthetic-peptide substrate (sequence:
FAEEEIYGEFEAKKKK). The reaction was terminated by centrifuga-
Btion followed by spotting 20 l of the supernatant onto What-
tman-81 chromatography paper. After extensive washing, the radio-
vactivity associated with the spots was determined by scintillation
counting. To ensure that the results obtained do not reflect varia- Gions in the amount of Lyn in the different groups, parallel sets of
mmunoprecipitates were also analyzed by Western blot using anti-
yn antibodies. Comparable Lyn-specific band intensities were ob-
ained in these experiments.
hosphatase Assay
his was done essentially as described earlier, using paranitrophe-
yl phosphate as the substrate (Hua et al., 1998; Yoshida and Kufe,
001). That comparable amounts of either SHP-1 or B220 were pre-
ent in the various tubes was again ensured through Western blot
n parallel sets of immunoprecipitates.
upplemental Data
upplemental Data include seven figures and are available with this
rticle online at http://www.cell.com/cg/content/full/121/2/281/DC1/.
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